146 related articles for article (PubMed ID: 6923744)
1. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
Mitchell EA; Quested C; Marks RE; Pinnock RE; Elliott RB
Aust Paediatr J; 1982 Jun; 18(2):114-7. PubMed ID: 6923744
[No Abstract] [Full Text] [Related]
2. Pancreatic enzyme supplement dosage in cystic fibrosis.
Owen G; Peters TJ; Dawson S; Goodchild MC
Lancet; 1991 Nov; 338(8775):1153. PubMed ID: 1682579
[No Abstract] [Full Text] [Related]
3. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
Ansaldi-Balocco N; Santini B; Sarchi C
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
Gow R; Bradbear R; Francis P; Shepherd R
Lancet; 1981 Nov; 2(8255):1071-4. PubMed ID: 6118524
[No Abstract] [Full Text] [Related]
5. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
Zsíros J; Sólyom E
Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773
[No Abstract] [Full Text] [Related]
6. Malabsorption in cystic fibrosis: mechanisms and treatment.
Bouquet J; Sinaasappel M; Neijens HJ
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S30-5. PubMed ID: 3404359
[TBL] [Abstract][Full Text] [Related]
7. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
Dutta SK; Tilley DK
J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
[No Abstract] [Full Text] [Related]
8. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis.
Warwick WJ; Budd JR
Clin Ther; 1982; 5(1):15-20. PubMed ID: 7127365
[TBL] [Abstract][Full Text] [Related]
9. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study.
Vyas H; Matthew DJ; Milla PJ
Eur J Pediatr; 1990 Jan; 149(4):241-3. PubMed ID: 1689245
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
Cho YW; Aviado DM
J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
[No Abstract] [Full Text] [Related]
11. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
Marotta F; O'Keefe SJ; Marks IN; Girdwood A; Young G
Dig Dis Sci; 1989 Mar; 34(3):456-61. PubMed ID: 2563963
[TBL] [Abstract][Full Text] [Related]
13. [Does enzyme substitution therapy reduce pain in chronic pancreatitis?].
Hansen ML; Rumessen JJ
Ugeskr Laeger; 2005 Apr; 167(17):1841-4. PubMed ID: 15929329
[No Abstract] [Full Text] [Related]
14. [Long-term treatment of mucoviscidosis. Results with a microencapsulated pancreatic enzyme preparation].
Henker J; Hoffmann D; Paul D; Hein J; Paditz E
Fortschr Med; 1993 Feb; 111(4):53-6. PubMed ID: 8449468
[TBL] [Abstract][Full Text] [Related]
15. Treatment of steatorrhoea in cystic fibrosis: a comparison of enteric-coated microspheres of pancreatin versus non-enteric-coated pancreatin and adjuvant cimetidine.
Stead RJ; Skypala I; Hodson ME
Aliment Pharmacol Ther; 1988 Dec; 2(6):471-82. PubMed ID: 2979269
[TBL] [Abstract][Full Text] [Related]
16. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation.
Stead RJ; Skypala I; Hodson ME; Batten JC
Thorax; 1987 Jul; 42(7):533-7. PubMed ID: 3326213
[TBL] [Abstract][Full Text] [Related]
17. Controversies in the treatment of exocrine pancreatic insufficiency.
DiMagno EP
Dig Dis Sci; 1982 Jun; 27(6):481-4. PubMed ID: 6919479
[No Abstract] [Full Text] [Related]
18. The management of enzymatic therapy in cystic fibrosis patients by an individualized approach.
Costantini D; Padoan R; Curcio L; Giunta A
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S36-9. PubMed ID: 3404360
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic enzyme replacement therapy.
Morrow JD
Am J Med Sci; 1989 Nov; 298(5):357-9. PubMed ID: 2683774
[No Abstract] [Full Text] [Related]
20. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
Zerega J; Lerner S; Meyer JH
Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
